ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO1425

Collapsing FSGS or Crescentic GN or Both: A Diagnostic Challenge

Session Information

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation

Authors

  • Malek, Irshadjahan, Division of Nephropathology, University of North Carolina, Chapel Hill, North Carolina, United States
  • Singh, Harsharan Kaur, Division of Nephropathology, University of North Carolina, Chapel Hill, North Carolina, United States
  • Nickeleit, Volker, Division of Nephropathology, University of North Carolina, Chapel Hill, North Carolina, United States
Introduction

The finding of an ANCA associated necrotizing & crescentic GN with collapsing FSGS is a rarity with only few reported cases in literature.

Case Description

A 53-yr-old AA female was admitted to hospital with difficulty in swallowing, poor oral intake, hemoptysis & AKI superimposed on CKD-III with hx of HTN & use of NSAIDs. Urine analysis showed hematuria, proteinuria & UPC ratio of 4.15. Blood analysis showed S.Cr 8.7mg/dl, BUN 60mg/dl, Albumin 2.4gm/dl, positive MPO ANCA & ANA titers. By light microscopy 36 glomeruli were present, 20% showed cellular/fibro-cellular crescent formation with underlying tuft fibrinoid necrosis & 20% showed collapsing FSGS. ATI, moderate IF/TA & moderate to severe arteriosclerosis were present. EM showed global podocyte activation with foot processes effacement.

Discussion

Collapsing FSGS and ANCA associated GN can both present with abrupt onset AKI & proteinuria. No specific test exists to separate crescents from collapsing FSGS; therefore this daunting differentiation requires a high level of suspicion, often relegated to experience. Most useful morphologic features are summarized in table 1. In our case, AA race (possible APOL1 risk variants) & underlying severe arterionephrosclerosis (ischemia) are the most likely etiologies for the collapsing FSGS.

MorphologyCollapsing FSGSCrescentic GN
Tuft Collapse++-
Podocytes hyperplasia/hypertrophy++-
Parietal epithelial cell hyperplasia-++
Tuft fibrinoid necrosis-++
Fibrin in extra capillary space+/-++
Podocytes protein resorption droplets +++ +/-
Inflammatory cells in extra capillary proliferation -+
Spindle cell elements/Myofibroblasts-+
Extracellular matrix deposition ++
Interstitial inflammation +-/++
RBC casts -++
ATI++
Tubular microcystic dilation ++++/-

A-Tuft collapse(arrow), podocytes hyperplasia/hypertrophy. B- Fibrinoid necrosis (arrow) & crescent formation(Trichrome stain x20)